Retrospective Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Dec 27, 2024; 16(12): 3745-3753
Published online Dec 27, 2024. doi: 10.4240/wjgs.v16.i12.3745
Table 1 Comparison of baseline data between the two groups of patients, n (%)
Baseline information
Group S (n = 35)
Group L (n = 35)
t/χ2
P value
Age (years)58.54 ± 13.1859.07 ± 13.760.1650.869
Body mass index (kg/m2)21.29 ± 1.9221.18 ± 2.050.2320.817
Sex0.0580.810
    Male19 (54.29)20 (57.14)
    Female16 (45.71)15 (42.86)
Tumor type0.2790.870
    Gastric cancer17 (48.57)16 (45.71)
    Rectum cancer10 (28.57)12 (34.29)
    Colon cancer8 (22.86)7 (20.00)
Tumor pathological grading0.3570.550
    Stage III6 (17.14)8 (22.86)
    Stage IV29 (82.86)27 (77.14)
Primary tumor diameter (cm)5.16 ± 1.835.31 ± 1.970.3300.742
Main distant metastatic organs
    Liver10 (28.57)13 (37.14)0.5830.445
    Lungs9 (25.71)11 (31.43)0.2800.597
    Peritoneum17 (48.57)22 (62.86)1.4470.229
    Lymph node15 (42.86)13 (37.14)0.2380.626
Degree of cancer pain0.2450.621
    Moderate14 (40.00)12 (34.29)
    Severe21 (60.00)23 (65.71)